1. Histological differentiation in human breast cancer is related to steroid receptors and stromal elastosis

   • Pierre Henri Rolland
   • Jocelyne Jacquemier
   • Pierre Marie Martin

   Original Articles Pages: 73 - 77

2. Comparative toxicity of detorubicin and doxorubicin, free and DNA-bound, for hemopoietic stem cells

   • Michel Huybrechts
   • André Trouet

   Original Articles Pages: 79 - 82

3. Deoxycoformycin toxicity in mice after long-term treatment

   • Ram P. Agarwal

   Original Articles Pages: 83 - 87

4. Amphotericin B plus combination chemotherapy for extensive non-small cell bronchogenic carcinoma

   • Gregory Sarna
   • Barry B. Lowitz
   • Martin J. Cline

   Original Articles Pages: 89 - 92

5. The clinical pharmacology of the adenosine deaminase inhibitor 2′-deoxycoformycin

   • John F. Smyth
   • Rosanne M. Paine
   • David G. Johns

   Original Articles Pages: 93 - 101

6. A characterization of the activity of α-1,3,5-triglycidyl-s-triazinetrione, a novel antineoplastic compound

   • Federico Spreafico
   • Ghanem Atassi
   • Donatella Boschetti

   Original Articles Pages: 103 - 108

7. Clinical pharmacology of tamoxifen and N-desmethyltamoxifen in patients with advanced breast cancer

   • Peter Wilkinson
   • Gerald Ribeiro
   • John Patterson

   Original Articles Pages: 109 - 111

8. Histopathological studies on antitumor effect of sporamycin

   • Yasuaki Kawakubo
   • Kanki Komiyama
   • Yasukazu Nishiyama

   Original Articles Pages: 113 - 118

9. Early detection of doxorubicin cardiotoxicity by M-mode echocardiography

   • W. Markiewicz
   • E. Robinson
   • A. Carter

   Original Articles Pages: 119 - 125

10. In vivo effects in mice produced by a 3′-branched homologue of α-2′-deoxythioguanosine

    • G. A. LePage
    • P. A. Banks
    • G. R. Buzzell

    Original Articles Pages: 127 - 131